Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
Safe, effective treatments that are more widely available than surgery are needed to combat obesity. Nonetheless, the FDA has voted against two new drugs and withdrawn another in 2010. Despite the uphill battle faced by those developing medical therapies, a number of studies demonstrate the variety of biological targets for obesity treatment.
The medical management of pituitary tumors is entering a new era. Novel compounds that directly target the pituitary tumor have shown promise in patients with treatment-refractory or recurrent Cushing disease and acromegaly. Furthermore, the alkylating agent temozolomide provides clinical benefit for patients with aggressive pituitary adenomas or carcinomas.
People are now living longer with type 2 diabetes mellitus; novel complications, such as dementia, could start to emerge. This Review discusses the mechanisms thought to underlie the association between type 2 diabetes mellitus and dementia.
The growth of disseminated tumor metastases is a major cause of mortality in patients with cancer, and bone is a common site for metastasis. This Review summarizes the cellular and molecular components of the metastatic cascade and highlights potential new directions for future therapeutic strategies to target bone metastasis.
